A CTLA-4 gene polymorphism at position −318 in the promoter region affects the expression of protein
Open Access
- 1 June 2002
- journal article
- research article
- Published by Springer Nature in Genes & Immunity
- Vol. 3 (4), 233-234
- https://doi.org/10.1038/sj.gene.6363869
Abstract
CTLA-4 is an important negative regulator of the immune system. The regulation of the CTLA-4 gene (Ctla-4) transcription is poorly understood. A single nucleotide polymorphism (SNP) at −318 in the Ctla-4 promoter region is associated with certain autoimmune diseases. Since the −318 SNP occurs in a potential regulatory region, it is conceivable that the C′ T transition may affect the expression of Ctla-4. In the present study, we show that the −318T allele is associated with a higher promoter activity than the −318C allele (8.13 ± 0.46 vs 6.87 ± 0.49). The presence of the −318T allele may thus contribute to up regulation of the expression of CTLA-4, and consequently represent one mechanism to inhibit exaggerated immune activity.Keywords
This publication has 6 references indexed in Scilit:
- CTLA-4 gene expression is influenced by promoter and exon 1 polymorphismsGenes & Immunity, 2001
- CTLA-4-Mediated Inhibition in Regulation of T Cell Responses: Mechanisms and Manipulation in Tumor ImmunotherapyAnnual Review of Immunology, 2001
- CTLA-4 dimorphisms in gammopathy-associated peripheral neuropathyEuropean Journal of Neurology, 1999
- CTLA4 polymorphisms in Spanish patients with rheumatoid arthritisTissue Antigens, 1999
- CTLA4 promoter and exon 1 dimorphisms in multiple sclerosisoTissue Antigens, 1999
- CTLA‐4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditisTissue Antigens, 1998